[go: up one dir, main page]

MA39336A1 - Anti-lag-3 antibody molecules and their uses - Google Patents

Anti-lag-3 antibody molecules and their uses

Info

Publication number
MA39336A1
MA39336A1 MA39336A MA39336A MA39336A1 MA 39336 A1 MA39336 A1 MA 39336A1 MA 39336 A MA39336 A MA 39336A MA 39336 A MA39336 A MA 39336A MA 39336 A1 MA39336 A1 MA 39336A1
Authority
MA
Morocco
Prior art keywords
lag
antibody molecules
treat
prevent
specifically bind
Prior art date
Application number
MA39336A
Other languages
French (fr)
Other versions
MA39336B1 (en
Inventor
Frederic Triebel
Chrystelle Brignone
Walter A Blattler
Jennifer Marie Mataraza
Catherine Anne Sabatos-Peyton
Hwai Wen Chang
Gerhard Johann Frey
Original Assignee
Novartis Ag
Immutep Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Immutep Sas filed Critical Novartis Ag
Priority claimed from PCT/US2015/020474 external-priority patent/WO2015138920A1/en
Publication of MA39336A1 publication Critical patent/MA39336A1/en
Publication of MA39336B1 publication Critical patent/MA39336B1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne des molécules d'anticorps qui se lient spécifiquement à lag-3. Les molécules d'anticorps anti-lag-3 peuvent être utilisées pour traiter, prévenir et/ou diagnostiquer des troubles cancéreux ou infectieux.The present invention relates to antibody molecules that specifically bind to lag-3. The anti-lag-3 antibody molecules can be used to treat, prevent and / or diagnose cancer or infectious disorders.

MA39336A 2014-03-14 2015-03-13 Anti-lag-3 antibody molecules and their uses MA39336B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461953536P 2014-03-14 2014-03-14
PCT/US2015/020474 WO2015138920A1 (en) 2014-03-14 2015-03-13 Antibody molecules to lag-3 and uses thereof

Publications (2)

Publication Number Publication Date
MA39336A1 true MA39336A1 (en) 2018-01-31
MA39336B1 MA39336B1 (en) 2019-03-29

Family

ID=58699967

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39336A MA39336B1 (en) 2014-03-14 2015-03-13 Anti-lag-3 antibody molecules and their uses

Country Status (2)

Country Link
AR (1) AR100041A1 (en)
MA (1) MA39336B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113603779B (en) * 2021-08-18 2023-06-02 深圳市元谷生物科技有限公司 Antibody combined with human lymphocyte activation gene 3 (LAG-3) and application thereof

Also Published As

Publication number Publication date
AR100041A1 (en) 2016-09-07
MA39336B1 (en) 2019-03-29

Similar Documents

Publication Publication Date Title
MA40035A (en) PD-L1 ANTIBODY MOLECULES AND THEIR USES
PH12019502875A1 (en) Antibody molecules to cd73 and uses thereof
MA44659B1 (en) ANTI-TIM-3 ANTIBODIES AND COMPOSITIONS
CY1122510T1 (en) ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF
MA46708B1 (en) Anti-pd1 antibodies and their uses
PH12018501206A1 (en) Antibody molecules to pd-1 and uses thereof
MA43187A (en) SUBCUTANEOUS ANTI-CD38 ANTIBODY FORMULATIONS AND THEIR USES
WO2019232244A3 (en) Antibody molecules to cd73 and uses thereof
EA201990594A1 (en) ANTI-TIM-3 ANTIBODIES AND THEIR APPLICATION
WO2017019894A8 (en) Combination therapies comprising antibody molecules to lag-3
PH12020550141A1 (en) Antibody molecules to cd138 and uses thereof
MA40576B1 (en) Anti-her2 antibodies and immunoconjugates
MA38814A1 (en) Gitr agonist and pd-1 antagonist for their uses in the treatment of proliferative disorders
WO2017120523A3 (en) Anti-pro/latent myostatin antibodies and methods of use thereof
MY197345A (en) Antibody molecules to april and uses thereof
MA40682B1 (en) Anti-ox40 antibodies and methods of use thereof
EA201691488A1 (en) ANTIBODY MOLECULES AGAINST PD-1 AND THEIR APPLICATIONS
MX2019015738A (en) Dosage regimens for anti-tim-3 antibodies and uses thereof.
MA43982A (en) ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USE FOR THE TREATMENT OR PREVENTION OF TYPE 1 DIABETES
MA46619B1 (en) Anti-il-33 antibodies and their uses
EP3455261A4 (en) ANTI-ROR2 ANTIBODIES, ANTIBODY FRAGMENTS, THEIR IMMUNOCONJUGATES AND USES THEREOF
MX2022008659A (en) Antibody molecules to c5ar1 and uses thereof.
MA42006A1 (en) Hybrid molecules
MA39336A1 (en) Anti-lag-3 antibody molecules and their uses
MA39208B1 (en) Anti-pd-1 antibody molecules and their uses